Related Experiment Videos

Clinical update on the use of recombinant factor VII

S Glazer¹, U Hedner, J F Falch

¹Biopharmaceuticals Division, Novo Nordisk A/S, Gentofte, Denmark.

Advances in Experimental Medicine and Biology

|January 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Motor Effects of Minimal Traumatic Brain Injury in Mice.

Journal of molecular neuroscience : MN·2019

A phase I clinical trial demonstrates that nfP2X7 -targeted antibodies provide a novel, safe and tolerable topical therapy for basal cell carcinoma.

The British journal of dermatology·2017

Progressive improvement in wound healing with increased therapy in haemophilia B mice.

Haemophilia : the official journal of the World Federation of Hemophilia·2013

Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.

Journal of thrombosis and haemostasis : JTH·2012

Antidote strategies to reverse anticoagulation with TB-402, a long-acting partial inhibitor of factor VIII.

Journal of thrombosis and haemostasis : JTH·2012

A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumours.

British journal of cancer·2012

See all related articles